Phunware makes patient navigation tools available on Epic's marketplace

Phunware Inc. (NASDAQ:PHUN) listed two healthcare products on Epic's marketplace, including Interactive Maps for indoor navigation and Patient Digital Front Door for pre-visit information. The tools aim to reduce late or missed appointments, benefiting health systems. CEO Dmitry Kroshka highlighted the potential to guide patients through procedures and recovery. Phunware 2.0 will integrate mobile, location-aware, and AI capabilities for various sectors.

Original reporting
Published Nov 12, 2026, 3:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 12, 2026, 3:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Phunware makes patient navigation tools available on Epic's marketplace — source image
Decision brief

The 30-second read

$PHUNNeutralLow
01

Why it matters

The new Epic marketplace listing could increase Phunware's visibility to hospitals, but the financial impact is uncertain.

02

Market read

A modest, first‑time product distribution channel for Phunware; limited immediate trading impact.

03

What to watch

Adoption speed, integration costs for health systems, and competition from other navigation platforms.

Relevance 5/10Novelty 5/10Timing: today

Background

Phunware provides location-based mobile solutions; Epic is a leading electronic health record platform.

Company-level read

Ticker impact

$PHUNNeutralMedium confidence
Context

Phunware announced its Interactive Maps and Wayfinding and Patient Digital Front Door products are now listed on Epic's marketplace, exposing the company to Epic health system customers.

Expected impact

modest upside as the listing may drive incremental sales to health systems using Epic.

Evidence & confidence

The announcement is new but the contract size is undisclosed; impact depends on adoption by Epic customers.

Market effects

Potential boost for digital health and patient navigation vendors that integrate with Epic.

U.S. healthcare technology market may see modest interest.

Limited to markets where Epic is deployed, primarily U.S.

Counterpoint

The Epic listing may not translate into significant revenue without large health system contracts.

Key entities

  • Phunware Inc

    Provider of location-aware mobile platforms.

  • Epic Systems

    Electronic health record software vendor.

Related articles

$PHUNMed

Phunware Reports Second Quarter 2026 Financial Results

Phunware, Inc. (PHUN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Phunware Reports Second Quarter 2026 Financial Results Revenue Increased 76% Year-Over-Year, Gross Margin Expanded to 69% Maintained $92 Million Cash Position with No Debt to Support Continued Product Innovation and Growth Appointed Chief Executive Officer and Senior Vice Preside

$AMDMedAI 8/10

AMD, Meta deepen partnership for AI infrastructure

AMD and Meta are expanding their partnership to build AI infrastructure, including processors, GPUs, and software. AMD will invest $1 billion in Meta. AMD's Helios, EPYC, and Instinct products support Meta's AI services, with future collaborations planned. The companies are also optimizing software for AI workloads. AMD CEO Lisa Su and Meta CEO Mark Zuckerberg highlighted the importance of the collaboration.

$TSLAMed

Tesla Cybercab goes on sale for $29,990, slated for December deliveries

Tesla begins sales of its Cybercab at $29,990, with deliveries starting in December. The vehicle requires a $299 monthly Autonomy Subscription and is designed for autonomous operation only. Production is at Gigafactory Texas, and initial deliveries are limited to Austin. Tesla also trimmed Model Y offerings, removing the Standard All-Wheel-Drive configuration. SpaceX is set to launch Starship Flight 15, aiming for the first full recovery of an orbital launch system.

MedAI 9/10

GlobalFoundries starts New York expansion with U.S.-Japan fab

GlobalFoundries began construction on two new semiconductor fabrication plants in Malta, New York, with a $21 billion investment. The project, part of a U.S.-Japan initiative, aims to boost U.S. semiconductor capacity and create jobs. Each new fab will add 900,000 wafers per year, supporting technologies like AI and automotive systems. The first plant is expected to open in 2029.

$GRIMedAI 9/10

GRI Bio 3Q 2026: EPS ($0.69) — 10-Q Summary

GRI Bio reported no revenue and a narrowed net loss for 3Q 2026, citing reduced spending on GRI-0621 development. The Phase 2a trial met endpoints with no serious adverse events. FDA granted Orphan Drug Designation for GRI-0621. The company plans to file an IND application for GRI-0803 in 2027.